Pharmacogenomics through Proteogenomics in Primary Care: Clinical Workflows, Outcomes, and Cost-Effectiveness

Kibibi Wairimu H.

School of Natural and Applied Sciences Kampala International University Uganda

ABSTRACT

Pharmacogenomics has emerged as a cornerstone of precision medicine, enabling safer and more effective prescribing through the identification of genetic determinants of drug response. Proteogenomics extends this approach by incorporating protein expression, modification, and functional data, offering a more comprehensive understanding of interindividual variability in therapeutic outcomes. This review examines the integration of pharmacogenomics through proteogenomics in primary care, focusing on clinical workflows, patient-centered outcomes, and cost-effectiveness. Evidence indicates that both pre-emptive and reactive testing models can support medication optimization, reduce adverse drug reactions, and improve adherence and clinical outcomes across multiple therapeutic areas, particularly psychiatric, respiratory, and cardiovascular conditions. Integration with electronic health records and clinical decision-support systems enhances real-time prescribing guidance and longitudinal patient management. Economic analyses suggest that pharmacogenomic-guided medication management can be cost-effective and may reduce healthcare utilization, although the high cost of proteomic assays and limited reimbursement remain barriers. Implementation challenges include a lack of workflow standardization, insufficient clinician training, limited population diversity in reference datasets, and translational gaps between research and routine practice. Strengthening implementation science, expanding diverse cohort studies, and developing standardized reporting frameworks will be essential to realizing the full clinical and economic potential of proteogenomics-enabled pharmacogenomics in primary care.

Keywords: Pharmacogenomics, Proteogenomics, Primary Care, Clinical Decision Support, and Cost-Effectiveness.

CITE AS: Kibibi Wairimu H. (2026). Pharmacogenomics through Proteogenomics in Primary Care: Clinical Workflows, Outcomes, and Cost-Effectiveness. RESEARCH INVENTION JOURNAL OF PUBLIC HEALTH AND PHARMACY 5(1): 20-29. https://doi.org/10.59298/RIJPP/2026/512029